Project Details
Description
The purpose of this study is to elucidate the metabolic and pharmacokinetic profile of IVX-E-59 in HIV-infected patients. The linearity of single-dose pharmacokinetics and absolute bioavailability of IVX-E-59 after oral administration will be assessed.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/94 → 9/30/95 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.